The global pharmacokinetics services market share is not just growing; it is geographically shifting. As the industry moves toward a projected valuation of US$ 1,579.87 million by 2031, the "where" of drug development is becoming as important as the "how." While traditional hubs maintain their lead through innovation, emerging markets are rapidly scaling their infrastructure to become global...